Related Experiment Video
Updated: Sep 19, 2025

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
Published on: June 25, 2018
Rice bran extract attenuates cognitive impairment by enhancing pancreatic β-cell insulin secretion in STZ-induced
Madonna Magdy Youssef1, Mohammed Farrag El-Yamany2, Reham Mahmoud Abdel-Kader3
1Pharmacovigilance Department, Egyptian Drug Authority, Giza, Egypt. Madonna.magdy@std.pharma.cu.edu.eg.
Insights
Egyptian RB ethanol extract (RBE) may improve Type I diabetes by boosting insulin secretion and restoring cognitive function in rats. This PPARγ activator shows promise for reversing diabetic complications and enhancing memory.
Area of Science:
- Endocrinology
- Neuroscience
- Pharmacology
Background:
- Type I diabetes (T1D) involves pancreatic beta-cell destruction, leading to cognitive impairments.
- Current insulin therapy has limitations, and restoring beta-cell function is a therapeutic goal.
- Peroxisome proliferator-activated receptor gamma (PPARγ) agonists may restore beta-cell biology.
Purpose of the Study:
- To investigate the molecular mechanism of Egyptian RB ethanol extract (RBE) in glucose-stimulated insulin secretion and beta-cell function restoration.
- To evaluate RBE's impact on cognitive function in a diabetic rat model.
Main Methods:
- A streptozotocin (STZ)-induced diabetic rat model was used with five treatment groups.
- Rats were treated daily with RBE or insulin for 21 days.
- Biochemical parameters, gene expression (PPAR/PDX1 pathway), cognitive behavior (Y-maze, NOR), and histology were assessed.
Main Results:
- RBE treatment normalized blood glucose, Glut2, Ca2+, and insulin levels in diabetic rats.
- Pancreatic insulin levels significantly increased with RBE compared to insulin treatment.
- RBE upregulated PPARγ, SERCA, and PrKC gene expression (excluding PDX1) and restored cognitive functions.
Conclusions:
- RBE demonstrates antidiabetic effects by enhancing insulin secretion and restoring beta-cell function.
- RBE may improve memory and cognition by modulating peripheral insulin secretion via PPARγ activation.
Abstract:
Type I diabetes (T1D), also known as juvenile diabetes, is an autoimmune disease that causes gradual destruction of pancreatic cells and leads to intellectual disability, neuropathy, cognitive impairment, and impaired learning ability in children. Despite standard treatment with synthetic human insulin, T1D patients can maintain up to 40% of their insulin-producing islets. PPARγ receptor activation research that aims to restore β-cell biology could help reverse the loss of pancreatic mass that comes with getting older and improve β-cell function. Egyptian RB ethanol extract (RBE), previously reported with PPARγ agonist activity, showed an increase in insulin secretion both in vivo and in INS-1 cells. The exact antidiabetic RBE mechanism is still unclear. The present study aims to investigate the molecular RBE mechanism in glucose-stimulating insulin secretion and restoration of β cell function. A diabetic rat streptozotocin (STZ) model was used; five groups were designed. The STZ-diabetic rats were treated with RBE daily for 21 days compared to an insulin-treated group. Biochemical parameters and quantitative RT-PCR of β-cell genes related to the PPAR/PDX1 signaling pathway were performed, and the influence on cognitive ability was confirmed by behavioral testing (Y-maze and NOR) and histological examination. The RBE-treated group reversed blood glucose, Glut2, Ca2 +, and insulin levels in diabetic rats, with pancreatic insulin levels significantly increasing compared to the insulin group. With the exception of PDX1, RBE boosted PPARγ, SERCA, and PrKC gene expression. RBE also restored cognitive functions. This study suggests that RBE may enhance memory and cognition by increasing peripheral insulin secretion through PPARγ regulator activity.
Related Concept Videos
Cell Specific Gene Expression
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

